Scaling Singapore biotech takes a global network, says ClavystBio’s Khoo Shih

Success for the Singapore biotech project will take a global network, one which Khoo Shih and other prominent drivers of the local ecosystem are keen to leverage to bring the right combination of talent, experience and capital to the growing hub.

Speaking on The BioCentury Show, Khoo Shih, CEO of investment firm ClavystBio, laid out the strategy for capitalizing on the ascendant energy and attention being devoted to Singapore biotech...